Specialist in HematologyLa Paz University HospitalMadrid, Madrid, Spain
PB0682 - In vitro Response to Bypassing Agents and Long Term Follow-up of Patients with Severe Hemophilia A on Prophylaxis with Emicizumab.
Monday, June 26, 202318:30 – 19:30 ET
